Published in J Antimicrob Chemother on April 28, 2014
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep (2010) 7.04
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol (1976) 3.61
Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep (2009) 3.43
Complications of viral influenza. Am J Med (2008) 3.28
The biology of influenza viruses. Vaccine (2008) 2.58
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis (2012) 2.52
Adaptation of pandemic H1N1 influenza viruses in mice. J Virol (2010) 2.22
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med (2009) 1.79
VIRUS STRUCTURE REVEALED BY NEGATIVE STAINING. Adv Virus Res (1963) 1.73
Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis (2012) 1.62
Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun (1984) 1.52
Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis (2011) 1.38
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer. Pediatr Infect Dis J (2011) 1.10
A morphological comparison of Bittner and influenza viruses. J Hyg (Lond) (1967) 1.09
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza. J Med Chem (2005) 1.07
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen. Antimicrob Agents Chemother (2004) 1.05
Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010. Emerg Infect Dis (2011) 1.03
Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient. Clin Microbiol Infect (2010) 0.95
Update: influenza activity - United States and worldwide, May 20-September 22, 2012. MMWR Morb Mortal Wkly Rep (2012) 0.89
The 2009 influenza pandemic: promising lessons for antiviral therapy for future outbreaks. Curr Med Chem (2011) 0.87
Therapeutics against influenza. Curr Top Microbiol Immunol (2013) 0.86
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase. Bioorg Med Chem Lett (2004) 0.84
Exacerbation of influenza virus infections in mice by intranasal treatments and implications for evaluation of antiviral drugs. Antimicrob Agents Chemother (2012) 0.83
The morphology of human immunodeficiency virus particles by negative staining electron microscopy. J Gen Virol (1987) 0.80
Electron microscopy of tobacco mosaic virus prepared with the aid of negative staining-carbon film techniques. J Gen Virol (1976) 0.79
Oseltamivir-resistant pandemic (H1N1) 2009 treated with nebulized zanamivir. Emerg Infect Dis (2010) 0.79
Infectious disease. Antiviral agents for the treatment and chemoprophylaxis of influenza. Ann Emerg Med (2011) 0.77